Literature DB >> 598420

The pharmacokinetics of carbamazepine.

L M Cotter, M J Eadie, W D Hooper, C M Lander, G A Smith, J H Tyrer.   

Abstract

The time-courses of plasma carbamazepine concentrations were followed in six apparently healthy adult subjects who, at different times, took single oral drug doses of 200, 400, 500, 600, 700, 800 and 900 mg. There were some suggestions of impaired bioavailability of the drug when given in tablet form. The following values were obtained for various pharmacokinetic parameters: kabs = 0.176 +/- 0.209 h-1; k = 0.0203 +/- 0.0055 h-1; T1/2 = 37.5 +/- 13.1 h; VD = 0.825 +/- 0.1041 . KG-1; Clearance = 0.0163 +/- 0.0061 1 . kg-1. The elimination rate constant showed a statistically significant increase with increasing drug dose. This may help explain the clinical observation that the rate of rise of steady state plasma carbamazepine concentrations tends to decrease with dose increase in patients taking carbamazepine alone.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 598420     DOI: 10.1007/bf00561065

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Pharmacokinetics of carbamazepine in normal humans after single and repeated oral doses.

Authors:  A P Géradin; F V Abadie; J A Campestrini; W Theobald
Journal:  J Pharmacokinet Biopharm       Date:  1976-12

2.  Pharmacokinetics of carbamazepine in normal man.

Authors:  R H Levy; W H Pitlick; A S Troupin; J R Green; J M Neal
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

3.  Quantitative assay for carbamazepine serum levels by gas-liquid chromatography.

Authors:  P Friel; J R Green
Journal:  Clin Chim Acta       Date:  1973-01-10       Impact factor: 3.786

4.  Factors influencing plasma carbamazepine concentrations.

Authors:  C M Lander; M J Eadie; J H Tyrer
Journal:  Clin Exp Neurol       Date:  1977

5.  Distribution and elimination kinetics of carbamazepine in man.

Authors:  M D Rawlins; P Collste; L Bertilsson; L Palmér
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

6.  Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.

Authors:  M Eichelbaum; K Ekbom; L Bertilsson; V A Ringberger; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

7.  Preliminary observations on the clinical pharmacology of carbamazepine ('Tegretol').

Authors:  W D Hooper; D K Dubetz; M J Eadie; J H Tyrer
Journal:  Proc Aust Assoc Neurol       Date:  1974
  7 in total
  9 in total

Review 1.  Therapeutic drug monitoring--antiepileptic drugs.

Authors:  M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

2.  Population pharmacokinetics of carbamazepine in Singapore epileptic patients.

Authors:  E Chan; H S Lee; S S Hue
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

3.  Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability.

Authors:  Amir Badshah; Fazal Subhan; Khalid Rauf
Journal:  AAPS PharmSciTech       Date:  2010-09-08       Impact factor: 3.246

Review 4.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 5.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

6.  Pharmacokinetics of carbamazepine. Part I: A new bioequivalency parameter based on a relative bioavailability trial.

Authors:  A Kayali; I Tuğlular; M Ertaş
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Oct-Dec       Impact factor: 2.441

7.  Investigating Oral Absorption of Carbamazepine in Pediatric Populations.

Authors:  Philip Kohlmann; Cordula Stillhart; Martin Kuentz; Neil Parrott
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

8.  Circadian effect on carbamazepine kinetics in rat.

Authors:  B Bruguerolle; M Valli; L Bouyard; G Jadot; P Bouyard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

Review 9.  Carbamazepine toxicity and poisoning. Incidence, clinical features and management.

Authors:  L Durelli; U Massazza; R Cavallo
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.